|
NSD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63136171238421E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.32420807231438E-12 |
| Normal-vs-Stage2 |
1.8509399999922E-05 |
| Normal-vs-Stage3 |
2.84505752290443E-12 |
| Normal-vs-Stage4 |
2.44559927864429E-11 |
| Stage1-vs-Stage2 |
5.611000E-01 |
| Stage1-vs-Stage3 |
7.928300E-02 |
| Stage1-vs-Stage4 |
7.497600E-03 |
| Stage2-vs-Stage3 |
8.661800E-02 |
| Stage2-vs-Stage4 |
1.873640E-02 |
| Stage3-vs-Stage4 |
3.386000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80806497446429E-14 |
| Normal-vs-AfricanAmerican |
3.353900E-04 |
| Normal-vs-Asian |
6.42999997690907E-09 |
| Caucasian-vs-AfricanAmerican |
4.249800E-01 |
| Caucasian-vs-Asian |
7.500400E-01 |
| AfricanAmerican-vs-Asian |
3.307800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01879615854727E-11 |
| Normal-vs-Female |
1.7643664307343E-12 |
| Male-vs-Female |
7.168600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.83569883924906E-11 |
| Normal-vs-Age(41-60Yrs) |
1.23310250899067E-11 |
| Normal-vs-Age(61-80Yrs) |
7.28960003471002E-10 |
| Normal-vs-Age(81-100Yrs) |
5.263900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.836200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.663400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.471800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.336000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.284400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.296200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.951040E-04 |
| Classical-VS-Follicular |
7.800800E-01 |
| Classical-VS-Other |
2.623800E-01 |
| Classical-VS-Normal |
2.47179999801617E-08 |
| Tall-VS-Follicular |
2.980700E-03 |
| Tall-VS-Other |
5.890600E-01 |
| Tall-VS-Normal |
4.97768493090689E-12 |
| Follicular-VS-Other |
3.673400E-01 |
| Follicular-VS-Normal |
4.43550000062132E-08 |
| Other-VS-Normal |
1.560990E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01159969290165E-10 |
| Normal-vs-N1 |
2.46860309971453E-11 |
| N0-vs-N1 |
2.146500E-02 |
|
|
